Send feedback

DYSF p.Pro1778Gln

c.5333C>A · rs145272777 · VCV285686

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 11 submitters
AlphaMissense
likely benign
0.0955 · ACMG-weighted
gnomAD v4.1
Rare
rare (popmax 0.232%, mid)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
5
neuromuscular disease caused by qualitative or quantitative defects of dysferlin

Computational evidence

Protein change
AlphaMissense0.0955likely benign
REVEL0.14moderately benign-leaning
SaProtLLR -7.95tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -0.19GERP 0.093
Regional constrainto/e 0.97unconstrained · MANE · 117 kb · p 0.28 · regional, not allelic
Overall
CADD16.95PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM P1739Q vs ClinVar P1778Q) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.232% Middle Eastern · 14/6,042 alleles
Filtering AF 0.14% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.112%
Overall 0.035% 565/1,614,116 alleles · rare
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.54% 185
Middle Easterngrpmax 0.232% 432
Remaining individualsnot grpmax-eligible 0.0784% 1,276
South Asian 0.0582% 1,719
Admixed American 0.0233% 4,287
European (non-Finnish) 0.0225% 4,436
Finnishnot grpmax-eligible 0.0109% 9,144
East Asian 0.00223% 44,882
African / African-American 0.00133% 75,012

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
DYSF
Protein
p.Pro1778Gln
Coding
c.5333C>A
MANE Select
NM_001130987
dbSNP
rs145272777
Type
single nucleotide variant
Location
chr2:71667391 (GRCh38)
Gene constraint
LOEUF 0.836 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 79.25 · 11 PDB
Full DYSF gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/dysf-p-pro1778gln (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown